Market revenue in 2023 | USD 255.4 million |
Market revenue in 2030 | USD 383.7 million |
Growth rate | 6% (CAGR from 2023 to 2030) |
Largest segment | Immunohistochemistry |
Fastest growing segment | Digital Pathology and Workflow |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.
Immunohistochemistry was the largest segment with a revenue share of 25.69% in 2023. Horizon Databook has segmented the Canada tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.
Breast cancer is a leading cancer type in Canada. Canada is the second largest market in North America tissue diagnostics. Canadian Breast Cancer Foundation is continually working for creating awareness about cancer, which creates growth opportunities for tissue diagnostics.
According to Canadian Cancer Society, approximately half of the Canadian population is expected to be diagnosed with cancer in their lifetime. As per 2017 annual report of Canadian Cancer Statistics, the number of cancer patients increased due to rise in geriatric population.
However, it was observed that survival rate has increased over the past few years due to cancer prevention programs, early detection methods, and better treatment options. Canadian Partnership Against Cancer maintains the Screening and Early Detection portfolio with partnerships across Canada.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada tissue diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Canada tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account